Table 2.
Type | CAC vs. NL |
CAC vs. IBD |
Correlation | Gene set |
---|---|---|---|---|
ΔS | ΔS | |||
Cluster B (TGFβ, KRT19, EpCAM) | ||||
BP | −0.60 | −0.50 | −0.83 | acute-phase response |
−0.69 | −0.63 | −0.86 | triglyceride metabolic process | |
−0.95 | −0.58 | −0.88 | blood coagulation, intrinsic pathway | |
−1.03 | −0.63 | −0.92 | complement activation | |
−1.09 | −0.70 | −0.93 | triglyceride homeostasis | |
MF | −0.59 | −0.51 | −0.75 | fatty acid binding |
−0.89 | −0.57 | −0.89 | lipid transporter activity | |
CC | −0.92 | −0.57 | −0.86 | very-low-density lipoprotein particle |
−0.99 | −0.68 | −0.88 | high-density lipoprotein particle | |
Myc | ||||
BP | 0.43 | 0.41 | 0.72 | translation |
CC | 0.63 | 0.48 | 0.77 | small nuclear ribonucleoprotein complex |
0.46 | 0.42 | 0.70 | ribonucleoprotein complex |
Note: CAC, cholangiocarcinoma; NL, normal liver; IDB, intrahepatic bile duct; BP, Biological process; MF, Molecular function; CC, Cellular component; ΔS difference of S-score